<?xml version="1.0" encoding="UTF-8"?><article>
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher">GJRA</journal-id>
			<journal-title>GJRA - Global Journal For Research Analysis</journal-title>
			<issn pub-type="ppub">2250 - 1991</issn>
			<publisher>
				<publisher-name>Indian Society for Health and Advanced Research</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="other">gjra-7-11-9744</article-id>
			<article-categories>
				<subj-group>
					<subject>Original Research Paper</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>A CLINICAL COMPARATIVE STUDY OF TWO INTUBATING DOSES OF CIS-ATRACURIUM DURING GENERAL ANAESTHESIA FOR RENAL TRANSPLANT SURGERIES.</article-title>
			</title-group>
			<contrib-group><contrib contrib-type="author">
						<name>
							<surname>Akruti</surname>
							<given-names>Modi</given-names>
							<prefix>Dr.</prefix>
						</name>
						<xref ref-type="aff" rid="aff000">
							<sup></sup>
						</xref>
						</contrib></contrib-group><pub-date pub-type="ppub">
				<month>November</month>
				<year>2018</year>
			</pub-date>
			<volume>7</volume>
			<issue>11</issue>
			<fpage>01</fpage>
			<lpage>02</lpage>
			<abstract>
				<title>ABSTRACT</title>
				<p>&amp;lt;p&amp;gt;&amp;amp;nbsp;&amp;lt;b&amp;gt;&amp;lt;span lang=&quot;EN-IN&quot; style=&quot;font-size:14.0pt;font-family:&amp;amp;quot;Times New Roman&amp;amp;quot;,&amp;amp;quot;serif&amp;amp;quot;&quot;&amp;gt;Introduction&amp;lt;/span&amp;gt;&amp;lt;/b&amp;gt;&amp;lt;span lang=&quot;EN-IN&quot; style=&quot;font-size: 14pt; font-family: &amp;amp;quot;Times New Roman&amp;amp;quot;, serif;&quot;&amp;gt;: Cisatracurium unlike atracurium is devoid of histamine-induced cardiovascular effects and this alone would be the greatest advantage in replacing atracurium for the facilitation of tracheal intubation. On the other hand, 2xED&amp;lt;sub&amp;gt;95 &amp;lt;/sub&amp;gt;dose of cisatracurium (100micro/kg) do not yield satisfactory intubating conditions such as those seen with equipotent doses atracurium and therefore there commended intubating dose of cisatracurium is 3xED&amp;lt;sub&amp;gt;95&amp;lt;/sub&amp;gt; . To understand better, we evaluated intubating condition with diferent doses of cisatracurium in renal transplant surgery.&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p class=&quot;MsoNormal&quot;&amp;gt;&amp;lt;b&amp;gt;&amp;lt;span lang=&quot;EN-IN&quot; style=&quot;font-size:14.0pt;font-family:&amp;amp;quot;Times New Roman&amp;amp;quot;,&amp;amp;quot;serif&amp;amp;quot;&quot;&amp;gt;Aims &amp;amp;amp; objectives&amp;lt;/span&amp;gt;&amp;lt;/b&amp;gt;&amp;lt;span lang=&quot;EN-IN&quot; style=&quot;font-size:14.0pt;font-family:&amp;amp;quot;Times New Roman&amp;amp;quot;,&amp;amp;quot;serif&amp;amp;quot;&quot;&amp;gt;: To evaluate and compare the intubating condition, duration of action, hemodynamic effects for different doses of cisatracurium.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p class=&quot;MsoNormal&quot;&amp;gt;&amp;lt;b&amp;gt;&amp;lt;span lang=&quot;EN-IN&quot; style=&quot;font-size:14.0pt;font-family:&amp;amp;quot;Times New Roman&amp;amp;quot;,&amp;amp;quot;serif&amp;amp;quot;&quot;&amp;gt;Material &amp;amp;amp; methods&amp;lt;/span&amp;gt;&amp;lt;/b&amp;gt;&amp;lt;span lang=&quot;EN-IN&quot; style=&quot;font-size:14.0pt;font-family:&amp;amp;quot;Times New Roman&amp;amp;quot;,&amp;amp;quot;serif&amp;amp;quot;&quot;&amp;gt;: After informed patient&amp;amp;rsquo;s consent 60 patients in age group of 20-50 years were selected and included in the study. Patients were divided in two groups of 30 each, GROUP-A received intravenously 2&amp;amp;times;ED&amp;lt;sub&amp;gt;95&amp;lt;/sub&amp;gt; (0.1mg/kg) dose of cisatracurium and GROUP-B received intravenously 3&amp;amp;times;ED&amp;lt;sub&amp;gt;95 &amp;lt;/sub&amp;gt;(0.15mg/kg) during induction.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;lt;span lang=&quot;EN-IN&quot; style=&quot;font-size:14.0pt;font-family:&amp;amp;quot;Times New Roman&amp;amp;quot;,&amp;amp;quot;serif&amp;amp;quot;;&amp;amp;#10;mso-fareast-font-family:&amp;amp;quot;Times New Roman&amp;amp;quot;;mso-fareast-theme-font:minor-fareast;&amp;amp;#10;mso-ansi-language:EN-IN;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA&quot;&amp;gt;&amp;amp;nbsp;&amp;lt;b&amp;gt;Results &amp;lt;/b&amp;gt;:Better intubating condition,hemodynamic stability and longer duration of action was found with 0.15mg/kgdose of Cisatracurium than 0.1mg/kg Cisatracurium in a induction&amp;amp;nbsp;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;</p>
			</abstract>			
			<counts>
				<ref-count count="7"/>
				<page-count count="2"/>
			</counts>
		</article-meta>
	</front>
</article>